Stem Cell, Services and Tissue Engineering
Regenerative Medicine services
At the forefront of medical innovation, regenerative medicine goes beyond merely managing diseases—it activates the body's innate ability to repair, regenerate, and restore the function of cells, tissues, and organs lost due to aging, disease, or injury. By targeting the root causes of health conditions, regenerative therapies aim to not only restore function but also rejuvenate the body to achieve optimal health and longevity. This revolutionary approach spans various medical specialties, offering new hope for improved quality of life and expanded treatment possibilities that elevate patient care to a whole new level.
Stem Cell Therapy
As pioneers in personalized medicine, HONYA Medical delivers cutting-edge stem cell services designed to meet individual patient needs. Stem cell therapy represents a monumental leap in medical treatment, addressing diseases at the cellular and genetic levels. Our high-quality, customized cell products are crafted based on comprehensive patient profiles, allowing for tailored therapies that address the underlying causes of illness, rather than just the symptoms. Collaborating with international experts, we bring the latest breakthroughs in stem cell technology to the forefront, offering personalized and transformative solutions that have the potential to cure diseases that were once deemed untreatable.
Tissue Engineering Solutions
Combining the science of cells, bioengineered scaffolds, and biocompatible materials, tissue engineering opens up new avenues for organ and tissue regeneration. The unique ability of stem cells to differentiate into any cell type within the body makes them a powerful tool in this field. HONYA Medical leverages automated culture systems and stem cell technologies to create personalized tissue constructs, enabling the replacement or enhancement of damaged tissues and organs. Our approach offers personalized, biologically compatible solutions that have the potential to revolutionize transplant medicine and improve patient outcomes across a wide range of conditions.
MiSaver®
Advancing Medicine, Healing Hearts
Technology
The Next Step in Medical Innovation Starts Here
HONYA Medical leverages advanced technology in stem cell therapy to revolutionize treatment options for various degenerative conditions. Their commitment to high-quality, ethically sourced stem cell products is evident in their rigorous manufacturing processes, adhering to Good Tissue Practice (GTP) and Good Manufacturing Practice (GMP) standards. This ensures that all products are produced with live, viable stem cells, ready for immediate use in clinical settings.
The company's technology encompasses innovative approaches in tissue engineering, utilizing a combination of cells, organ scaffolds, and biosynthetic materials. This enables the creation of personalized tissue constructs that can replace or improve damaged organs and tissues. Automated culture systems facilitate the efficient production of these tailored solutions, allowing for greater accessibility and affordability of stem cell therapies.
Developing the next generation of cell products
We focus on developing strictly controlled, fully automated, highly efficient, and scalable cell manufacturing technologies to produce the highest quality cell-based products at a commercial scale.
We have developed a state-of-the-art proprietary system that provides our cells with a microenvironment similar to that of the human body. As we change the conditions to transform it into unique cell preparation products, our cells...
Rapidly expand while maintaining health and strength. Our advanced manufacturing technology allows for the mass production of cell products with batch-to-batch consistency, making them true commercial products.
Product
New Hope for Patients - Cell Therapy
- Introducing the MiSaver® stem cell therapy product, a cutting-edge solution engineered to revolutionize cardiac care. MiSaver harnesses advanced stem cell technology to regenerate and repair heart tissue, specifically designed for patients who have suffered from acute myocardial infarction (AMI). By injecting high-potency stem cells directly into damaged cardiac regions, MiSaver activates the body's natural repair mechanisms, promoting tissue regeneration, enhancing heart function, and improving recovery outcomes.
- As a flagship product of HONYA Medical, MiSaver is the embodiment of years of research and innovation in regenerative medicine. It offers unprecedented potential for hospitals and healthcare providers to offer a clinically proven, life-saving treatment. Designed with flexibility for OEM partnerships and supported through a patient self-sponsorship program, MiSaver represents a new frontier in cardiovascular therapy.
Clinical trial
For a better future
At HONYA Medical, clinical trials form the backbone of our commitment to developing safe, effective, and innovative stem cell therapies. Our trials are meticulously designed to validate the therapeutic potential of our cutting-edge products, including MiSaver®, aimed at treating acute myocardial infarction (AMI), and other conditions affecting cardiovascular and degenerative diseases.
We follow rigorous international standards in clinical research, ensuring patient safety and scientific integrity at every phase. HONYA partners with leading medical institutions globally to conduct clinical trials, allowing us to gather critical data on the efficacy and safety of our stem cell treatments. Our current trials are focused on demonstrating how stem cell therapy can not only halt disease progression but also restore function and health in conditions previously considered untreatable.
With each trial, HONYA Medical moves closer to transforming the future of regenerative medicine. By turning scientific breakthroughs into real-world treatments, we offer new hope to patients worldwide. Stay updated with our latest clinical trial advancements to witness how innovation is reshaping healthcare.
MCRcI®
- MCRcI®It is a cellular product that is separated from the products of human birth. These cells have regenerative potential due to their ability to release factors that can respond to chemical signals from damaged tissues.
- These therapeutic factors trigger the body's own repair mechanisms and stimulate tissue renewal, differentiation, regeneration, and repair.
MiSaver®
MiSaver is the next generation of stem cell therapy, specifically designed to tackle the life-threatening effects of acute myocardial infarction (AMI). This pioneering treatment leverages the regenerative power of stem cells to repair damaged heart tissue, offering a cutting-edge solution for heart attack recovery. Through proprietary techniques, MiSaver's stem cells are delivered directly to the site of injury, where they activate the body’s natural healing process, promoting the regeneration of cardiac tissue and improving overall heart function.
The M series of cell line products have demonstrated efficacy in preclinical studies for neurological, cardiovascular, renal, and metabolic diseases, as well as various musculoskeletal disease models. Our research department continues to investigate the mechanisms of action of our different cell products, conducting multiple preclinical studies on our two main products (primarily for other indications), and continues to develop new products.
